D1 and D2 dopamine receptors and the regulation of striatal acetylcholine release in vivo.
Consolo
S
S
Laboratory of Cholinergic Neuropharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Girotti
P
P
Zambelli
M
M
Russi
G
G
Benzi
M
M
Bertorelli
R
R
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000494:pharmacology; D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D002839:Chromans / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism*; D003913:Dextroamphetamine / Q000494:pharmacology; D015259:Dopamine Agents / Q000494:pharmacology; D018492:Dopamine Antagonists; D005260:Female; D017551:Microdialysis; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D012636:Secretory Rate
D001552:Benzazepines; D002839:Chromans; D015259:Dopamine Agents; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; C058081:ecopipam; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D010293:Pargyline; C065380:A 68930; D000109:Acetylcholine; D003913:Dextroamphetamine